NCT06611696 - Avacopan vs Reduced-dose Glucocorticoids in ANCA-associated Vasculitis | Biotech Hunter

Enrollment

160

Participants

Timeline

Start Date

November 15, 2024

Primary Completion Date

March 31, 2027

Study Completion Date

September 30, 2028

Conditions

ANCA Associated Vasculitis (AAV)

Interventions

DRUG

Avacopan, prednisolone and rituximab

Patients in the avacoapn group will be treated with avacoapn, short-term reduced-dose prednisolone and rituximab.

DRUG

Prednisolone and rituximab

Patients in the glucocorticoid arm will be treated with reduced-dose prednisolone and rituximab.

Trial Locations (22)

1138431

RECRUITING

Juntendo Univeristy, Bunkyoku

1438541

RECRUITING

Toho University, Ōta-ku

1738606

RECRUITING

Teikyo University, tabashi City

1818611

RECRUITING

Kyorin University, Mitaka

2168511

RECRUITING

St.Marianna University School of Medicine, Kawasaki

2600852

RECRUITING

Chiba Aoba Municipal Hospital, Chiba

2608677

RECRUITING

Chiba University, Chiba

2868520

RECRUITING

International University of Health and Welfare, Narita

2868523

RECRUITING

Japanese Red Cross Narita Hospital, Narita

2892511

RECRUITING

Asahi General Hospital, Asahi

2900003

RECRUITING

Chiba Rosai Hospital, Ichihara

2968602

RECRUITING

Kameda Medical Centre, Kamogawa

3210293

RECRUITING

Dokkyo Medical University, Mibu

3508550

RECRUITING

Saitama Medical University, Kawagoe

3718511

RECRUITING

Gunma University, Maebashi

4093898

RECRUITING

Yamanashi University, Chuo-shi

4701192

NOT_YET_RECRUITING

Fujita Health University Hospital, Toyoake

5308480

RECRUITING

Kitano Hospital, Osaka

7008558

RECRUITING

Okayama University, Okayama

7610793

RECRUITING

Kagawa University, Hiragi

8528501

RECRUITING

Nagasaki University, Nagasaki

9808574

RECRUITING

Tohoku Univerisity, Sendai